Annual Drug Patent Expirations for KALETRA
Kaletra is a drug marketed by Abbvie and is included in three NDAs. It is available from three suppliers.
Drug patent litigation for KALETRA.
The generic ingredient in KALETRA is lopinavir; ritonavir. Three suppliers are listed for this compound. Additional details are available on the lopinavir; ritonavir profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
